WuXi AppTec Co. will face fresh questions about its growth prospects after the Pentagon named the major pharmaceutical contractor on a list of firms associated with the Chinese military, a move that could also complicate research being done by American drugmakers.
The Chinese company has performed various services for many of the world’s largest pharmaceutical companies, including drug discovery and commercial manufacturing. As of 2024, WuXi was producing much of the active base ingredient used in Eli Lilly & Co.’s obesity drug Zepbound, Bloomberg has reported.
The Defense Department’s designation is the latest sign of tension between the US ...
